Loading...
Clindamycin
India Pharmaceutical Trade Intelligence
Who Supplies Clindamycin to India from CHINA
India's clindamycin imports from CHINA total $8.2M across 5 shipments from 3 foreign suppliers. CHONGQING CARELIFE PHARMACEUTICAL CO LIMITED leads with $7.8M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CASPER PHARMA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for clindamycin — a concentrated sourcing relationship with select suppliers from CHINA.
Top foreign suppliers (CHINA) — Ranked by import value
CHONGQING CARELIFE PHARMACEUTICAL CO LIMITED is the leading Clindamycin supplier from CHINA to India, with import value of $7.8M across 2 shipments. The top 5 suppliers — CHONGQING CARELIFE PHARMACEUTICAL CO LIMITED, XXONGXXNG XXRELXXE PXXRMAXXUTIXXL XX LTX, ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO LTD — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (CHINA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CHONGQING CARELIFE PHARMACEUTICAL CO LIMITED | $7.8M | 2 | 95.1% |
| 2 | XXONGXXNG XXRELXXE PXXRMAXXUTIXXL XX LTX | $398.3K | 2 | 4.9% |
| 3 | ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO LTD | $2.2K | 1 | 0.0% |
Showing top 3 of 3 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CHINA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CASPER PHARMA PRIVATE LIMITED | $8.2M | 4 | 100.0% |
| 2 | APPCURE LABS PRIVATE LIMITED | $2.2K | 1 | 0.0% |
Import Statistics
- Import Value
- $8.2M
- Shipments
- 5
- Foreign Suppliers
- 3
- Indian Buyers
- 2
- Avg. Shipment
- $1.6M
Other Clindamycin Import Origins
Related Analysis
Frequently Asked Questions — Clindamycin Imports from CHINA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Clindamycin suppliers from CHINA to India?
The top Clindamycin suppliers from CHINA to India include CHONGQING CARELIFE PHARMACEUTICAL CO LIMITED, XXONGXXNG XXRELXXE PXXRMAXXUTIXXL XX LTX, ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO LTD. The leading supplier is CHONGQING CARELIFE PHARMACEUTICAL CO LIMITED with import value of $7.8M USD across 2 shipments. India imported Clindamycin worth $8.2M USD from CHINA in total across 5 shipments.
QHow much Clindamycin does India import from CHINA?
India imported Clindamycin worth $8.2M USD from CHINA across 5 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Clindamycin from CHINA?
The main Indian buyers of Clindamycin sourced from CHINA include CASPER PHARMA PRIVATE LIMITED, APPCURE LABS PRIVATE LIMITED. The largest buyer is CASPER PHARMA PRIVATE LIMITED with $8.2M in imports across 4 shipments.
QWhat is the total value of Clindamycin imports from CHINA to India?
The total value of Clindamycin imports from CHINA to India is $8.2M USD, across 5 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CHINA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Clindamycin.
- 2.Supplier/Buyer Matching: 3 foreign suppliers from CHINA and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $8.2M aggregated from 5 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5 Verified Shipments
3 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists